199 related articles for article (PubMed ID: 19553661)
21. Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody.
Karpusas M; Lucci J; Ferrant J; Benjamin C; Taylor FR; Strauch K; Garber E; Hsu YM
Structure; 2001 Apr; 9(4):321-9. PubMed ID: 11525169
[TBL] [Abstract][Full Text] [Related]
22. Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1.
Redpath NT; Xu Y; Wilson NJ; Fabri LJ; Baca M; Andrews AE; Braley H; Lu P; Ireland C; Ernst RE; Woods A; Forrest G; An Z; Zaller DM; Strohl WR; Luo CS; Czabotar PE; Garrett TP; Hilton DJ; Nash AD; Zhang JG; Nicola NA
Biochem J; 2013 Apr; 451(2):165-75. PubMed ID: 23384096
[TBL] [Abstract][Full Text] [Related]
23. Structural Analysis of Der p 1-Antibody Complexes and Comparison with Complexes of Proteins or Peptides with Monoclonal Antibodies.
Osinski T; Pomés A; Majorek KA; Glesner J; Offermann LR; Vailes LD; Chapman MD; Minor W; Chruszcz M
J Immunol; 2015 Jul; 195(1):307-16. PubMed ID: 26026055
[TBL] [Abstract][Full Text] [Related]
24. Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change.
Kanyo ZF; Pan KM; Williamson RA; Burton DR; Prusiner SB; Fletterick RJ; Cohen FE
J Mol Biol; 1999 Nov; 293(4):855-63. PubMed ID: 10543972
[TBL] [Abstract][Full Text] [Related]
25. Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody.
Ishchenko A; Wacker D; Kapoor M; Zhang A; Han GW; Basu S; Patel N; Messerschmidt M; Weierstall U; Liu W; Katritch V; Roth BL; Stevens RC; Cherezov V
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8223-8228. PubMed ID: 28716900
[TBL] [Abstract][Full Text] [Related]
26. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.
Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H
Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870
[TBL] [Abstract][Full Text] [Related]
27. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.
Muller YA; Chen Y; Christinger HW; Li B; Cunningham BC; Lowman HB; de Vos AM
Structure; 1998 Sep; 6(9):1153-67. PubMed ID: 9753694
[TBL] [Abstract][Full Text] [Related]
28. X-ray crystal structure localizes the mechanism of inhibition of an IL-36R antagonist monoclonal antibody to interaction with Ig1 and Ig2 extra cellular domains.
Larson ET; Brennan DL; Hickey ER; Ganesan R; Kroe-Barrett R; Farrow NA
Protein Sci; 2020 Jul; 29(7):1679-1686. PubMed ID: 32239732
[TBL] [Abstract][Full Text] [Related]
29. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
[TBL] [Abstract][Full Text] [Related]
30. Epitope mapping of anti-interleukin-13 neutralizing antibody CNTO607.
Teplyakov A; Obmolova G; Wu SJ; Luo J; Kang J; O'Neil K; Gilliland GL
J Mol Biol; 2009 May; 389(1):115-23. PubMed ID: 19361524
[TBL] [Abstract][Full Text] [Related]
31. Predicting molecular interactions and inducible complementarity: fragment docking of Fab-peptide complexes.
Friedman AR; Roberts VA; Tainer JA
Proteins; 1994 Sep; 20(1):15-24. PubMed ID: 7529922
[TBL] [Abstract][Full Text] [Related]
32. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.
Venkatramani L; Bochkareva E; Lee JT; Gulati U; Graeme Laver W; Bochkarev A; Air GM
J Mol Biol; 2006 Feb; 356(3):651-63. PubMed ID: 16384583
[TBL] [Abstract][Full Text] [Related]
33. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
34. A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain.
Flicker S; Vrtala S; Steinberger P; Vangelista L; Bufe A; Petersen A; Ghannadan M; Sperr WR; Valent P; Norderhaug L; Bohle B; Stockinger H; Suphioglu C; Ong EK; Kraft D; Valenta R
J Immunol; 2000 Oct; 165(7):3849-59. PubMed ID: 11034391
[TBL] [Abstract][Full Text] [Related]
35. Noncanonical conformation of CDR L1 in the anti-IL-23 antibody CNTO4088.
Teplyakov A; Obmolova G; Rogers A; Gilliland GL
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Mar; 66(Pt 3):229-32. PubMed ID: 20208149
[TBL] [Abstract][Full Text] [Related]
36. IL-18 receptor beta-induced changes in the presentation of IL-18 binding sites affect ligand binding and signal transduction.
Wu C; Sakorafas P; Miller R; McCarthy D; Scesney S; Dixon R; Ghayur T
J Immunol; 2003 Jun; 170(11):5571-7. PubMed ID: 12759435
[TBL] [Abstract][Full Text] [Related]
37. Structure of Fab fragment of malaria transmission blocking antibody 2A8 against P. vivax P25 protein.
Saxena AK
Int J Biol Macromol; 2012 Jan; 50(1):153-6. PubMed ID: 22037467
[TBL] [Abstract][Full Text] [Related]
38. Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1.
Baral PK; Wieland B; Swayampakula M; Polymenidou M; Rahman MH; Kav NN; Aguzzi A; James MN
Acta Crystallogr D Biol Crystallogr; 2012 Nov; 68(Pt 11):1501-12. PubMed ID: 23090399
[TBL] [Abstract][Full Text] [Related]
39. Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20.
Du J; Yang H; Guo Y; Ding J
Mol Immunol; 2009 Jul; 46(11-12):2419-23. PubMed ID: 19427037
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the antigen-binding fragment of apoptosis-inducing mouse anti-human Fas monoclonal antibody HFE7A.
Ito S; Takayama T; Hanzawa H; Ichikawa K; Ohsumi J; Serizawa N; Hata T; Haruyama H
J Biochem; 2002 Jan; 131(1):137-43. PubMed ID: 11754745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
